Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Soft-tissue Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Temporarily pausedNCT05958199
What this trial is testing

NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 131
Testing effectiveness (Phase 2)Study completedNCT02511132
What this trial is testing

A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma

Who this might be right for
Ewing's Sarcoma
Gradalis, Inc. 22
Early research (Phase 1)Study completedNCT00742924
What this trial is testing

Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 24
Not applicableStudy completedNCT01053494
What this trial is testing

Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+84 more
Wake Forest University Health Sciences 80
Not applicableEnded earlyNCT02720796
What this trial is testing

Patient-Derived Xenograft (PDX) Modeling in Adult Patients With Metastatic or Recurrent Sarcoma

Who this might be right for
Sarcoma
Champions Oncology 17
Not applicableStudy completedNCT01624220
What this trial is testing

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

Who this might be right for
Spinal Tumor
M.D. Anderson Cancer Center 41
Post-approval studies (Phase 4)UnknownNCT00339118
What this trial is testing

EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children

Who this might be right for
Rhabdomyosarcoma
Sheba Medical Center
Early research (Phase 1)Study completedNCT01139346
What this trial is testing

Study of Oral Darinaparsin in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Alaunos Therapeutics 12
Not applicableStudy completedNCT04540588
What this trial is testing

Retreatment With Intratumoral Diffusing Alpha Radiation Emitters

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 2
Testing effectiveness (Phase 2)Looking for participantsNCT05679921
What this trial is testing

Pazopanib With or Without Pembrolizumab for Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Yonsei University 116
Testing effectiveness (Phase 2)Study completedNCT00023998
What this trial is testing

Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma

Who this might be right for
Metastatic Osteosarcoma
National Cancer Institute (NCI) 80
Large-scale testing (Phase 3)UnknownNCT00002516
What this trial is testing

Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma

Who this might be right for
Sarcoma
University Hospital Muenster
Testing effectiveness (Phase 2)Looking for participantsNCT03093116
What this trial is testing

Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid Tumors
Turning Point Therapeutics, Inc. 500
Testing effectiveness (Phase 2)Ended earlyNCT03132155
What this trial is testing

QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma

Who this might be right for
Clear Cell Sarcoma
NantPharma, LLC 8
Early research (Phase 1)Study completedNCT01343043
What this trial is testing

A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma

Who this might be right for
Neoplasms
GlaxoSmithKline 50
Testing effectiveness (Phase 2)Study completedNCT00918489
What this trial is testing

Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)

Who this might be right for
Soft Tissue Sarcoma
Heidelberg University 40
Testing effectiveness (Phase 2)Looking for participantsNCT04094610
What this trial is testing

Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid TumorsLymphoma+1 more
Turning Point Therapeutics, Inc. 75
Testing effectiveness (Phase 2)WithdrawnNCT05174455
What this trial is testing

Niraparib for the Treatment of Leiomyosarcoma

Who this might be right for
Locally Advanced LeiomyosarcomaMetastatic LeiomyosarcomaStage III Retroperitoneal Sarcoma AJCC v8+4 more
David Liebner, MD
Not applicableUnknownNCT05107843
What this trial is testing

Integrated Clinical-radiological Analysis of Hypoxia Markers in Pediatric Osteosarcomas

Who this might be right for
Osteosarcoma in Children
University Hospital, Strasbourg, France 30
Not applicableStudy completedNCT05131815
What this trial is testing

The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors

Who this might be right for
CancerCancer MetastaticNeoplasms+19 more
Cedars-Sinai Medical Center 8
Next Page